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Open access under the ElseviPolybrominated Diphenyl Ethers (PBDEs) are an important class of ﬂame retardants with a wide range of
toxic effects on biotic and abiotic systems. The toxic mechanisms of PBDEs are still not completely under-
stood because there are several different congeners with different chemical and biological characteristics.
BDE-99 is one of these, widely found in the environment and biological samples, showing evidence of
neurotoxic and endocrine disruption activities, but with little information about its action mechanism
described in the current literature. This work investigated the effects of BDE-99 on the HepG2 cell line
in order to clarify its toxic mechanism, using concentrations of 0.5–25 lM (24 and 48 h). Our results
showed that BDE-99 could cause cell death in the higher concentrations, its activity being related to a
decrease in mitochondrial membrane potential and an accumulation of ROS. It was also shown that
BDE-99 induced the exposure of phosphatidylserine, caspases 3 and 9 activation and DNA fragmentation
in HepG2 cells, without causing the release of LDH. Thus it was shown that BDE-99 could cause HepG2
cell death by apoptosis, suggesting its toxicity to the human liver.
 2012 Elsevier Ltd. Open access under the Elsevier OA license.1. Introduction
Scientiﬁc and technological development brings beneﬁts and
advantages to our modern lifestyle. Innovation is currently a
necessity due to the great demand for new consumer products,
but this also brings serious consequences to the current and future
generations due to factors such as air, soil and water pollution as
related to the release of several chemicals potentially harmful to
the environment and human health.
Amongst these compounds are the brominated ﬂame retardants
(BFRs) that represent a class of contaminants widely used in con-
sumer products due to their high efﬁciency in inhibiting or mini-
mizing the effects caused by ﬁres, and their low cost;
representing 25% of the world market of ﬂame retardants (Hardy,
1999). However it has been shown that they persist in the environ-
ment and show high bioaccumulation potential, being classiﬁed as
persistent organic pollutants (POPs).
Polybrominated Diphenyl Ethers (PBDEs) are a class of BFRs
used as additives in plastics, textiles, electronic circuits and equip-
ments, building materials and many other consumer goods. They
are added during the manufacture of various products in daily
use, but no effective chemical bonds occurred during the process: +55 16 36024838.
).
er OA license.which would cause their release into the environment during
manipulation or improper disposal (Mcdonald, 2002).
The bioaccumulation potential of PBDEs and their persistence in
the environment are due to their lipophilicity, and high levels of
these compounds have been detected in samples of animal fats,
blood, placenta and breast milk. (Covaci et al., 2009; Hites, 2004;
Li et al., 2008; Ma et al., 2012; Shen et al., 2010; Letcher et al.,
2010; Toms et al., 2007). The main contamination routes for hu-
mans are house dust and contaminated foods (Branchi et al.,
2003; Talsness, 2008).
Amongst the effects described as caused by exposure to PBDEs,
there is evidence of a neurotoxic potential (Branchi et al., 2003;
Madia et al., 2004; Verner et al., 2011) and changes in the endo-
crine system, by acting on hormone receptors such as estrogen
and progesterone, and decreasing the levels of the thyroid hor-
mones (Costa and Giordano, 2007; Costa et al., 2008; Madia
et al., 2004; McDonald, 2002; Zhang et al., 2008). They have also
being related to the development of liver toxicity and thyroid can-
cer (Albina et al., 2010; Hu et al., 2007; Zhang et al., 2008), but the
mechanisms underlying these effects are still not completely
understood.
2,20,4,40 Tetrabromodiphenyl ether (BDE-47) and 2,20,4,40,5
pentabromodiphenyl ether (BDE-99) are the most commonly
found congeners in environmental samples and biological systems,
and show high levels of toxicity. In vitro investigations have shown
A.O. Souza et al. / Toxicology in Vitro 27 (2013) 580–587 581that some PBDE congeners, such as BDE-47 and BDE-209, present
cytotoxic potential in several cell lines such as HepG2 (Madia
et al., 2004; Jing et al., 2010; Weihong et al., 2008; Hu et al.,
2007, 2009; Yan et al., 2011), however little is known about the ini-
tial events that trigger these effects. In addition, there are no data
about the effects of BDE-99 on HepG2 cells, a fact that makes it dif-
ﬁcult to compare the different congeners. Therefore an investiga-
tion of the toxic effects of congeners with different amounts of
bromine substituents is required, in order to better understand
the mechanism of action of this class of compounds.
Reports have demonstrated that BDE-99 is found mainly in the
liver of humans or animals, and is related to the development of
hepatoxicity (Albina et al., 2010) which can be due to the original
compound or to the metabolites that can be more toxic than the
original congener (Gandhi et al., 2011). So, hepatic cell models
are important experimental tools to investigate their action
mechanism.
HepG2 cells are derived from human hepatoblastoma and are
widely used in several in vitro assays (Knasmuller et al., 1998).
Due to the need for more data about the toxicity of the PBDEs
and particularly about the consequences of exposure to BDE-99,
this work proposed to investigate its effects on HepG2 cells.2. Materials and methods
2.1. Cell culture
HepG2 cells (American Type Culture Collection, n HB8065)
were cultured in ‘‘Minimum Essential Medium’’ MEM supple-
mented with 10% fetal calf serum in an atmosphere containing
5% CO2 at 37 C until the cells reached a conﬂuence suitable for
starting testing. After this procedure, adequate amounts of cells
were plated and incubated for 24 h to ensure good adhesion before
initiating the experiments.
2.2. Reagents
Congener BDE-99 was purchased from AccuStandard (New
Haven, USA). Sulforhodamine B (SRB), 3 (4,5 dimethylthiazol-2-
il)-2,5 Diphenyltetrazolium Bromide (MTT), Dimethyl Sulfoxide
(DMSO), Propidium Iodide (PI), tert-Butyl hydroperoxide solution
(TBHP), Triton X-100 and bisBenzimide H 33342 trihydrochloride
(Hoechst 33342) were purchased from Sigma–Aldrich (EUA).
Tetramethylrhodamine Methyl Ester (TMRM), Fetal Bovine
Serum (GIBCO), 5,6-Chloromethyl-20,70-Dichlorodihydroﬂuoresce-
in Diacetate, Acetyl Ester (CM-H2DCFDA) and ‘‘Minimum Essential
Medium’’ MEM (GIBCO) were purchased from Invitrogen (USA).
Annexin V-FITC was purchased from Proteimax (Brazil) and the
Cisplatin Solution (Citoplax) from Bergamo (Brazil). All other
reagents were of the highest commercial degree. The amounts of
Dimethyl Sulfoxide (DMSO) required to dissolve the BDE-99 had
no effect on the assays. All stock solutions were prepared using
glass-distilled deionized water.
2.3. Cell proliferation assay
In order to evaluate the effects of several concentrations of the
BDE-99, cell proliferation was assessed using the SRB colorimetric
assay according to Skehan et al. (1990).
Brieﬂy, HepG2 cells were cultured to a density of 5  104 cells.
The cultures were then exposed to BDE-99 at ﬁnal concentrations
ranging from 0.5 to 25 lM. Each sample had at least three repli-
cates and was cultured for 24 and 48 h. The media were then dis-
carded and the cells washed once with phosphate buffer saline
(PBS) and twice with distilled water to remove the salts.After this procedure, the cells were dried at room temperature
and subsequently ﬁxed in a 1% methanol in 1% acetic acid solution
for 2 h. The ﬁxed cells were stained with a 0.5% SRB in 1% acetic
acid solution, and then washed with a 1% acetic acid solution to re-
move the excess probe. The SRB attached to the cell membranes
was extracted using 1 ml of a 10 mM Tris solution, pH 10.0. The
absorbance of the dye was then measured at a wavelength of
540 nm in a microplate reader (Varian Cary 50MPR, Varian, USA).2.4. Cell viability assay (MTT assay)
Cell viability was assessed using a (4,5 dimethylthiazole-2-il)-
2,5 diphenyltetrazolium bromide dye, according to Denizot and
Lang (1986).
HepG2 cells were seeded with a density of 1  105 cells and ex-
posed to BDE-99 at ﬁnal concentrations ranging from 0.5 to 25 lM.
At least three replicates were made for each sample and cultured
for 24 and 48 h. The cells were subsequently incubated with a
0.5% MTT (5 mg/mL) solution in an atmosphere containing 5%
CO2 at 37 C for 3 h. After this period, the medium in the wells
was discarded and the formazan crystals formed dissolved in a
DMSO solution in 0.2 M glycine buffer, pH 10.2. The ﬁnal absor-
bance was evaluated at 570 nm wavelength in a microplate reader
(Varian Cary 50MPR, Varian, USA). The results were shown as the
percentage difference from the control group.2.5. Mitochondrial membrane potential
Indications of cell damage can be evaluated by mitochondrial
depolarization, since the collapse of the membrane potential com-
promises the cell energy and consequently damages cell integrity.
Mitochondrial depolarization can be measured using the ﬂuores-
cent dye TMRM, a cation compound permeable to cell membranes,
which is rapidly sequestered by the mitochondria of intact cells,
and produces a stoichiometric relationship between the ﬂuores-
cence and the mitochondrial membrane potential (Imberti et al.,
1993).
The HepG2 cells were cultured to a density of 1  105 cells and
then exposed to BDE-99 at ﬁnal concentrations ranging from 0.5 to
25 lM. Each sample was tested with at least three replicates. The
cells were then washed with PBS, trypsinised and incubated with
a 6.6 lM TMRM solution at 37 C for 30 min. The samples were
subsequently lysed with a 0.1% Triton X-100 solution (v/v) and
the TMRM captured and retained by the mitochondria measured
at the excitation and emission wavelengths of 485 and 590 nm,
respectively, using a F-4500 ﬂuorescence spectrophotometer (Hit-
achi, Tokyo, Japan). The results are shown as the percentage of
ﬂuorescence in relation to the control group.2.6. Accumulation of reactive oxygen species (ROS)
The accumulation of ROS can be evaluated using CM-H2DCFDA,
a reactive oxygen species indicator that becomes ﬂuorescent in the
presence of intracellular oxidation (Chernyak et al., 2006).
The HepG2 cells were cultured to a density of 1  105 cells.
After incubation with BDE-99, the cells were further incubated
with a 2 mM CM-H2DCF-DA solution at 37 C for 1 h. The ﬂuores-
cence of the CM-H2DCFDA was subsequently measured using a F-
4500 ﬂuorescence spectrophotometer (Hitachi, Tokyo, Japan) the
excitation and emission wavelengths of at 503 and 528 nm, respec-
tively. The results were shown as the difference from the control
group. A tert-butyl hydroperoxide (100 lM) solution was used to
induce oxidative stress.
Fig. 1. The effects of BDE-99 (0.5–25 lM) on the proliferation of the HepG2 cell line
after 24 and 48 h of exposure to the compound. Cell line proliferation was assessed
using sulforhodamine B (SRB), as described in Section 2. The data are presented as
the means ± SEM of a series of three experiments with different cell cultures.
⁄Signiﬁcantly different (p < 0.05) from the negative control (without BDE-99).
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(Annexin V assay)
The exposure of phosphatidylserine on the outer cell membrane
is the ﬁrst sign that indicates the cells are undergoing apoptosis.
Annexin-V is a protein with a high afﬁnity for membrane phospho-
lipids, and its use combined with a ﬂuorescent agent has been
widely used to assess phosphatidylserine externalization during
the apoptotic process (Zhivotovsky et al., 1999).
The HepG2 cells were cultured to a density of 1  105 cells and
then treated with BDE-99 at the same concentrations that showed
greater effects in the viability and proliferation cell assays. Each
sample was tested with at least three replicates. The cells were
then incubated with a 0.25 lg/ml FITC-Annexin-V solution and a
0.5 lg/ml Propidium Iodide solution and incubated for 15 min.
The cells were analyzed using a BD-FACSCANTO™ ﬂow cytometer
(BD Bioscience, CA, USA) and BD-FACSDIVA software (BD Biosci-
ence, CA, USA).
2.8. Cell membrane integrity
The cell membrane integrity was assessed by measuring the
lactate dehydrogenase (LDH, EC: 1.1.1.27) released using a com-
mercially available kit (LDH UV) (Labtest, Brazil).
The HepG2 cells were cultured and treated with the BDE-99
concentrations that presented the greatest effects in the viability
and proliferation cell assays for 24 and 48 h. After cell exposure
to BDE-99, the cell culture media were collected and the LDH re-
leased evaluated from the decrease in absorbance during 4 min
in a Model U-2910 Hitachi spectrophotometer (Japan).
The LDH activity was calculated using the formula:
LDH Activity ¼ ½ðAbstime00  Abstime40 Þ=total time  8095
The cells were washed with PBS, trypsinised, incubated with the
same volume of 0.4% (w/v) trypan blue solution for 3 min, and the
viable (with no membrane damage) and non-viable (with mem-
brane damage) cells counted using a light microscope and recorded
(Altman et al., 1993).
2.9. Nuclear fragmentation
Nuclear fragmentation was assessed using the ﬂuorescent dye
Hoechst 33342. Brieﬂy, HepG2 cells were seeded on coverslips at
a density of 1  104 cells and treated with BDE-99 at the concen-
trations that presented the highest results in the viability and pro-
liferation cell assays for 24 and 48 h. Each sample was tested with
at least three replicates. The cells on the coverslips were then ﬁxed
with methanol at 20 C for 2 h and then staining with 5 lg/mL
Hoechst 33342 for 30 min at 37 C (Holly, 2002).
Nuclear fragments were observed using a Leica DM 5000B ﬂuo-
rescence microscope (Germany) and 300 cells quantiﬁed per slide.
2.10. Caspase-9 and caspase-3 activities assay
Caspase-9 and caspase-3 activities were assayed using the cas-
pase-3 ﬂuorimetric assay kit and caspases-9 ﬂuorimetric assay kit
according to the manufacturer’s instructions (Sigma–Aldrich).
After 24 h treatment, cells were suspended in 50lL of lyses buffer,
kept on ice for 15 min, and then centrifuged (14,000g, 15mim at
4 C). The supernatants were collected for the assays. Activation
of caspase-9 is based on hydrolysis of the substrate n-Acetyl-Leu-
Glu-His-Asp7-amido-4-triﬂuoromethylcoumarin (Ac-LEHD-AFC)
by caspase-9, resulting in the release of ﬂuorescent 7-amino-4-
triﬂuromethyl coumarin (AFC) moiety, while hydrolysis of the
peptide substrate acetyl-Asp-Glu-Val-Asp-7-amido-4-methyl-coumarin (Ac-DEVD-AMC) by caspase-3, resulted in the release
of the ﬂuorescent 7-amino-4-methylcoumarin (AMC) moiety.
Reaction were performed in buffer containing supernatant pro-
teins (50 lg/sample for caspase-9 and 25 lg/Sample for caspase-3)
and caspase substrates, at 37 C for 2 h, followed by ﬂuorimetric
detection using the excitation and emission wavelengths of 400/
505 nm and 360/460 nm for caspase-9 and caspase-3, respectively.
2.11. Statistical analysis
The experimental data were evaluated using the analysis of var-
iance (ANOVA), followed by the Dunnet test for the comparison of
the various treated groups with their controls, using the GraphP-
rism program, version 5.1 for Windows. The results were consid-
ered statistically signiﬁcant at p < 0.05.3. Results
The results showed that the congener BDE-99 inhibited cell pro-
liferation after 24 and 48 h of incubation, showing signiﬁcant ef-
fects at the higher concentrations tested (18.22 ± 6.42% and
41.77 ± 10.5% for 10 lM and 25 lM, respectively) after 24 h of
exposure. A signiﬁcant effect was observed for concentrations as
low as 0.5 lM when the cells were exposed to the compound for
48 h (Fig. 1).
Moreover, it was also demonstrated that the congener BDE-99
was able to induce a decrease in cell viability during both incuba-
tion periods for almost all the concentrations that lead to an inhi-
bition of HepG2 cell proliferation (Fig. 2). These results
demonstrated that there is a correlation between the effects ob-
served in the ﬁrst two experiments.
Fig. 3 shows the effect of BDE-99 on the mitochondrial mem-
brane potential (MMP). The MMP also changed after exposure to
10 and 25 lM of the compound for 24 h. This effect was intensiﬁed
after 48 h of incubation, showing signiﬁcant effects in concentra-
tions as low as 0.5 lM.
Similar results to those of the MMP assay were observed in the
ROS accumulation test. Fig. 4 shows a signiﬁcant increase in ROS
accumulation after 24 h of incubation with BDE-99 at the highest
concentration tested (25 lM). However when the effect was eval-
uated for 48 h, the exposure to 5 lM of the compound was sufﬁ-
cient to signiﬁcantly increase ROS accumulation in the HepG2 cells.
To better understand the mechanism by which BDE-99 induces
cell death, we evaluated the exposure of phosphatidyl serine on the
outer cell membrane by assessing the FITC-annexin-V positive
Fig. 2. The effects of BDE-99 (0.5–25 lM) on the viability of the HepG2 cell line
after 24 and 48 h of exposure to the compound. Cell viability was assessed using
(4,5 dimethylthiazol-2-il)-2,5 diphenyltetrazolium bromide dye (MTT assay), as
described in Section 2. The data are presented as the means ± SEM of a series of
three experiments with different cell cultures. ⁄Signiﬁcantly different (p < 0.05)
from the negative control (without BDE-99).
Fig. 3. The effects of BDE-99 (0.5–25 lM) on the mitochondrial membrane potential o
mitochondrial membrane potential was assessed using TMRM (tetramethyrodamine, me
series of three experiments with different cell cultures. ⁄Signiﬁcantly different (p < 0.05)
control.
Fig. 4. The effects of BDE-99 (0.5–25 lM) on the induction of ROS accumulation in the
accumulation was assessed using the ﬂuorescence probe 5,6-Chloromethyl-20 ,70-Dichloro
The data are presented as the means ± SEM of a series of three experiments with differen
BDE-99). Terc-butyl hydroperoxide (TBHP) 100 lM was used as the positive control.
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tive cells at the same concentrations that had decreased cell viabil-
ity and proliferation after 24 h of exposure to BDE-99. It was also
shown that after 48 h of exposure (Fig. 6) to this compound, con-
centrations starting at 5 lM were able to induce phosphatidyl ser-
ine exposure. On the other hand there was no increase in PI
positive cells at any concentration or time tested.
In order to conﬁrm these ﬁndings, the lactate dehydrogenase
activity was assessed after 24 and 48 h of cell exposure to BDE-
99. No difference was observed for any of the concentrations tested
for either of the exposure times (data not shown), showing that the
exposure to BDE-99 did not damage the cell membrane, which
would allow the release of the cell contents. This effect was con-
ﬁrmed by the trypan blue exclusion assessment, which did not de-
tect any signiﬁcant damage to the cell membrane (data not
shown).
Additionally, since exposure of phosphatidyl serine on the outer
cell membrane is a caspase-dependent mechanism, we evaluated
the caspases-9 and -3 activation after exposure to BDE-99.f the HepG2 cell line after 24 (A) and 48 h (B) of exposure to the compound. The
thyl ester) as described in Section 2. The data are presented as the means ± SEM of a
from the negative control (without BDE-99). CCCP (25 lM) was used as the positive
HepG2 cell line after 24 (A) and 48 h (B) of cell exposure to the compound. ROS
dihydroﬂuorescein Diacetate, Acetyl Ester (CM-H2DCFDA) as described in Section 2.
t cell cultures. ⁄Signiﬁcantly different (p < 0.05) from the negative control (without
Fig. 5. The effects of BDE-99 (0.5–25 lM) on the exposure of phosphatidylserine by the HepG2 cell line after 24 h of cell exposure to the compound. Phosphatidylserine
exposure was assessed by the Annexin-V (Anex.)/Propidium Iodide (PI) assay, as described in Section 2. The images are representative of three experiments with different cell
cultures, A (PI+ and Anex), B (PI+ and Anex+), C (PI and Anex+) and D (PI and Anex) are presented as the means ± SEM of a series of three experiments. ⁄Signiﬁcantly
different (p < 0.05) from the negative control (without BDE-99). A 1 mg/mL solution of cisplatin (cDDP) was used as the positive control.
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bation with 5, 10 and 25 lM of the compound for 24 h in a concen-
tration-dependent manner, while Fig. 7B demonstrated that only
exposure to 25 lM of BDE-99 induced a signiﬁcant increase in cas-
pase-3 activity in the same incubation period.
Finally, to conﬁrm the induction of apoptosis suggested by the
increase in annexin-V positive cells, we evaluated the nuclear frag-
mentation induced by BDE-99 by ﬂuorescence microscopy, using
the Hoechst 33342 dye. Fig. 8 demonstrates the presence of nucle-
ar fragmentation after exposure to BDE-99 at concentrations of 10
and 25 lM for 24 h, with an increase in the amount of nuclear frag-
mentation with longer periods of incubation.4. Discussion
BDE-99 is a PBDE congener with little information about its tox-
icity to human health, and the mechanisms by which it can inter-
fere with cell viability are still poorly understood. Since BDE-99 is
one of the most common congeners found in the environment, it is
an optimal candidate for toxicological evaluations, and in addition,
PBDEs are resistant to degradation and can cause damage that will
affect current and future generations.
Thus an evaluation of the interference with cell proliferation is a
tool widely used to investigate the toxic mechanisms of different
compounds, since it is an essential process for maintaining the
homeostasis of living organisms. The effect on cell proliferation
can occur by the inhibition of cell growth, leading to cell death,
or by DNA damage with the subsequent production of a mutatedcell with inappropriate proliferation and abnormal growth (Guo
and Hay, 1999).
BDE-99 decreases HepG2 cell proliferation in a concentration-
dependent manner that increases with the time of cell exposure
to the compound. Moreover, BDE-99 decreased cell viability when
assessed by the MTT assay at the same concentrations that inter-
fered with cell proliferation, demonstrating that at least part of
the observed effect on the proliferation was actually due to its abil-
ity to induce cell death.
It has already been described in the literature that other cong-
eners, such as BDE-209 and BDE-47, decreased the number of cells
with functional mitochondria as assessed by the sameMTTmethod
(Hu et al., 2007, 2009). These same groups also described the abil-
ity of BDE-47 and BDE-209 to induce apoptosis in HepG2 cells.
BDE-99 has also been reported to induce cell death in cortical cul-
tured cells at concentrations of 10 and 30 lM (Alm et al., 2010), the
same range of concentration that we observed a decrease in HepG2
cell viability.
In order to better understand the mechanisms underlying BDE-
99 toxicity and to observe if this congener would have the same
ability to induce apoptosis in HepG2 cells, its ability to interfere
with cell mitochondria was ﬁrst measured. A decrease in the mito-
chondrial membrane potential was observed at almost all the con-
centrations that induced cell death (10–25 lM after 24 h of
incubation and 0.5–25 lM after 48 h). This decrease in the mito-
chondrial membrane potential could occur due to an opening of
the mitochondrial permeability transition pores, which would re-
lease proteins such as cytochrome c, that trigger the apoptotic
pathway (Grivicich et al., 2007).
Fig. 6. The effects of BDE-99 (0.5–25 lM) on the exposure of phosphatidylserine by the HepG2 cell line after 48 h of cell exposure to the compound. Phosphatidylserine
exposure was assessed by the Annexin-V (Anex.)/Propidium Iodide (PI) assay, as described in Section 2. The images are representative of three experiments with different cell
cultures, A (PI+ and Anex), B (PI+ and Anex+), C (PI and Anex+) and D (PI and Anex) are presented as the means ± SEM of a series of three experiments. ⁄Signiﬁcantly
different (p < 0.05) from the negative control (without BDE-99). A 1 mg/mL solution of cisplatin (cDDP) was used as the positive control.
Fig. 7. The effects of BDE-99 (0.5–25 lM for 24 h) on caspase-9 and caspase-3 activities. Caspases activities were assessed using the commercially available ﬂuorimetric assay
kits as described in Section 2. Relative Fluorescence Unit (R.F.U.) was evaluated for each assay. The data are presented as the means ± SEM of a series of three experiments
with different cell cultures. _. ⁄Signiﬁcantly different (p < 0.05) from the negative control (without BDE-99).
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in the mitochondrial membrane potential and accumulation of
ROS. Therefore, just as observed for the BDE-209 and BDE-47 cong-
eners, the toxic effects of BDE-99 are related to ROS accumulation
(Hu et al., 2007; Huang et al., 2010; Shao et al., 2008; Weihong
et al., 2008).
We also evaluated the ability of BDE-99 to induce apoptosis.
Apoptotic cell death is associated with characteristics such as
phosphatidylserine exposure due to selective oxidation (Tyurinaet al., 2000; Matsura et al., 2005). Our results showed that high lev-
els of ROS induced by cell exposure to BDE-99 were followed by
phosphatidylserine exposure, suggesting that ROS accumulation
induced by BDE-99 can lead to apoptosis.
In addition, the LDH leakage studies showed no increase in LDH
after exposure to BDE-99, which together with the absence of PI
stained cells and the continued ability of the cells to exclude trypan
blue, suggests that the necrosis pathway is not relevant in BDE-99
induced HepG2 toxicity. However, there is controversy about the
Fig. 8. The effects of BDE-99 (0.5–25 lM for 24 h) on nuclear fragmentation of the HepG2 cell line. Nuclear Fragmentation was assessed using the ﬂuorescent dye Hoechst
33342 using ﬂuorescence microscopy as described in Section 2. The data are presented as the means ± SEM of a series of three experiments with different cell cultures.
⁄Signiﬁcantly different (p < 0.05) from the negative control (without BDE-99). A 1 mg/mL solution of cisplatin (cDDP) was used as the positive control.
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reported to cause a concentration-dependent inhibition of MTT
reduction and LDH leakage in human neuroblastoma cells (He
et al., 2008), and HepG2 cells (Hu et al., 2007), whereas BDE-99
(up to 100 lM) did not induce the release of LDH in human astro-
cytoma cells cultured for 24 h, even though the MTT had decreased
signiﬁcantly (Madia et al., 2004). This last ﬁnding is in agreement
with the present results for the same BDE congener.
The present results also conﬁrmed that the apoptotic pathway
was induced by HepG2 exposure to BDE-99 by assessing other
characteristics of this process, that is chromatin condensation
and DNA fragmentation, which were assessed by ﬂuorescence
microscopy using the dye Hoescht 33342, and an increased
amount of DNA fragmentation was observed in a concentration-
dependent manner. Furthermore, apoptotic pathway was also con-
ﬁrmed by the evaluation of caspases activities, which showed an
increased activation of caspase-9 and caspase-3 after 24 h of expo-
sure to the compound.
Other published works had already demonstrated that some
PBDEs congeners could induce apoptosis in vitro, such as BDE-
209 in HepG2 cells (Hu et al., 2007), however this is the ﬁrst time
that it was shown that the induction of apoptosis by BDE-99 in
HepG2 cells might involve mitochondrial dysfunction.
In summary, the present research contributed data that helps
clarify the toxicity of PBDEs. These results showed that the conge-
ner BDE-99 induced cell death in HepG2 cells by the apoptosis
pathway, interfering with the mitochondrial membrane potential
and inducing the accumulation of ROS.
Despite the above proposed toxic mechanism of BDE-99, it
should be considered that PBDEs can be metabolized in the liver,
producing less brominated metabolites and oxidative metabolites,
such as hydroxylated BDE congeners, which can present higher
toxicity than the original compound (Dong et al., 2010). So, studies
with the PBDEs metabolites need to be done in order to better
understand the extension of their toxicity to humans.
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